TELIMMUNE PLASMA SEPARATION CARDS
Traditional practice to produce viable blood plasma samples for clinical analysis is complex, time-limited and requires significant investment in training, disposables, cold chain transport and clinical infrastructure. Required steps include venipuncture phlebotomy, centrifugation, refrigeration, biohazard mitigation and cold-chain transport to a laboratory, all to ensure sample viability prior to analysis.
The Telimmune Card offers a simple, cost-effective alternative method to produce a volumetric, 3uL plasma sample that is stable when dried, eliminates in-vitro metabolic effects along with requirements for both cold-chain and biohazard transport.
Common applications include remote-to-laboratory blood-plasma collection, metabolic studies, biomarker screening, drug testing, longitudinal studies.
TECHNICAL SPECIFICATIONS
PHYSICAL PROPERTIES
​
-
FDA class 1 medical device
-
Compatible with standard 96 well formats
-
Hematocrit independent
-
Temperature range -5°F to 110°F
-
Volumetric precision: 5%
HIGH SENSITIVITY ANALYTICAL TECHNIQUES
​
-
LC/MS
-
ELISA
-
PCR
-
QPCR
-
Enzymatic
COMPETITIVE ADVANTAGES
TESTIMONIAL
“Duchenne Muscular Dystrophy (DMD) boys’ veins are challenging to phlebotomize. Given the painful hardship multiple blood draws pose, we collaborated with a team of experts to rapidly develop and validate a novel method using the Telimmune Duo Plasma Separation Cards which requires only two drops of whole blood from a finger stick!
This innovative technology provides exceptional precision and stability for measuring our drug product's pharmacokinetic (PK) profile and its metabolite, thereby circumventing the pain and inconvenience of multiple venipunctures for DMD boys. We couldn’t be more thrilled by the results of our validation and stability analyses using the Telimmune Plasma Separation Cards and look forward to generating the PK profiles of our drug product using them in our ongoing DMD clinical trial.”